The purpose of this study is to learn how patients with primary ciliary dyskinesia (PCD) clear mucus based on their genetic mutation. We also want to learn if albuterol can help patients clear mucus from their airways better.
Thank you for your interest, but this study is not currently enrolling.
United States (Nationwide)
Lawrence Ostrowski
Medicine-Pulmonary
Clinical or Medical
Observational
Healthy Volunteer or General Population
Lungs and Breathing
Rare Diseases
20-3465
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
